Free Trial

U.S. Physical Therapy (NYSE:USPH) Upgraded by Wall Street Zen to Buy Rating

U.S. Physical Therapy logo with Medical background

Key Points

  • U.S. Physical Therapy has been upgraded from a "hold" to a "buy" rating by Wall Street Zen as of Saturday, indicating increased confidence among analysts regarding the company's stock performance.
  • Barrington Research raised its price target for U.S. Physical Therapy shares from $98.00 to $103.00, contributing to a consensus price target of $110.25 among analysts.
  • The company reported $0.81 earnings per share for the last quarter, exceeding expectations and marking an 18.0% increase in revenue year-over-year.
  • Interested in U.S. Physical Therapy? Here are five stocks we like better.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "buy" rating in a research report issued on Saturday.

USPH has been the subject of several other research reports. Barrington Research increased their target price on shares of U.S. Physical Therapy from $98.00 to $103.00 and gave the stock an "outperform" rating in a research note on Friday, August 8th. Zacks Research upgraded shares of U.S. Physical Therapy to a "hold" rating in a research note on Friday, August 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have assigned a Hold rating to the company's stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

View Our Latest Report on U.S. Physical Therapy

U.S. Physical Therapy Stock Down 1.7%

U.S. Physical Therapy stock opened at $80.66 on Friday. U.S. Physical Therapy has a fifty-two week low of $62.77 and a fifty-two week high of $101.19. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.18 and a current ratio of 1.18. The company has a market capitalization of $1.23 billion, a P/E ratio of 35.22, a PEG ratio of 4.11 and a beta of 1.47. The stock has a 50-day simple moving average of $79.97 and a 200-day simple moving average of $76.58.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, August 6th. The company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.71 by $0.10. U.S. Physical Therapy had a return on equity of 8.78% and a net margin of 5.05%.The business had revenue of $197.34 million during the quarter, compared to the consensus estimate of $190.24 million. During the same period in the previous year, the business earned $0.73 EPS. The business's quarterly revenue was up 18.0% on a year-over-year basis. Equities research analysts expect that U.S. Physical Therapy will post 2.67 earnings per share for the current year.

Insider Buying and Selling

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 2,000 shares of the firm's stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $83.53, for a total value of $167,060.00. Following the sale, the chief executive officer owned 114,088 shares in the company, valued at approximately $9,529,770.64. This trade represents a 1.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Graham D. Reeve sold 763 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $84.97, for a total transaction of $64,832.11. Following the completion of the sale, the chief operating officer owned 21,483 shares in the company, valued at $1,825,410.51. The trade was a 3.43% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,853 shares of company stock valued at $581,406 in the last ninety days. Insiders own 2.00% of the company's stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in USPH. Assetmark Inc. boosted its holdings in U.S. Physical Therapy by 35.7% during the second quarter. Assetmark Inc. now owns 570 shares of the company's stock worth $45,000 after buying an additional 150 shares in the last quarter. Portside Wealth Group LLC boosted its holdings in U.S. Physical Therapy by 3.9% during the first quarter. Portside Wealth Group LLC now owns 4,108 shares of the company's stock worth $297,000 after buying an additional 154 shares in the last quarter. Osaic Holdings Inc. boosted its holdings in U.S. Physical Therapy by 1.6% during the second quarter. Osaic Holdings Inc. now owns 10,447 shares of the company's stock worth $817,000 after buying an additional 166 shares in the last quarter. Police & Firemen s Retirement System of New Jersey boosted its holdings in U.S. Physical Therapy by 5.7% during the second quarter. Police & Firemen s Retirement System of New Jersey now owns 3,247 shares of the company's stock worth $254,000 after buying an additional 176 shares in the last quarter. Finally, Precision Wealth Strategies LLC boosted its holdings in U.S. Physical Therapy by 6.6% during the first quarter. Precision Wealth Strategies LLC now owns 3,054 shares of the company's stock worth $221,000 after buying an additional 189 shares in the last quarter.

U.S. Physical Therapy Company Profile

(Get Free Report)

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

See Also

Analyst Recommendations for U.S. Physical Therapy (NYSE:USPH)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in U.S. Physical Therapy Right Now?

Before you consider U.S. Physical Therapy, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and U.S. Physical Therapy wasn't on the list.

While U.S. Physical Therapy currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.